Exploring the genetics of glaucoma and retinal development

November 10, 2017 by Will Doss
Immunostaining of a developing neuroretina (red) surrounding the lens (nuclei in yellow). F-actin-expressing cells are in green. Credit: Northwestern University

Guillermo Oliver, PhD, the Thomas D. Spies Professor of Lymphatic Metabolism, recently published two studies related to the eye, one on retinal formation and the other on the genetics behind glaucoma.

Oliver was the senior author of a Cell Reports publication, which used stem and induced to generate eye organoids that mimic early eye development, as a tool to characterize molecular events regulating the formation of this complex organ.

The lead author was Nozomu Takata, PhD, a postdoctoral fellow in Oliver's lab. Other Northwestern Medicine authors included Luciano Fiore, PhD, Sandra Acosta, PhD, and Hyea Jin Gil, PhD; all postdoctoral fellows in Oliver's lab.

Oliver is also a professor of Medicine in the Division of Nephrology and Hypertension, and the director of the Center for Vascular and Developmental Biology at the Feinberg Cardiovascular Research Institute.

Recent advances in 3D stem cell cultures facilitated the use of lab models that closely mimic actual tissue development, allowing scientists to better understand the molecular and morphogenetic processes underlying organ development. This study looked at the neuroretina, a collection of eye cells that help convert light into neural signals.

Using these tools, the scientists identified a gene—Rspondin-2—as a critical player in mammalian neuroretina differentiation, according to Oliver.

The authors found that during early development, when the eye is initially forming and is still just an outgrowth of neural tissue, the activity of the transcription factor Six3 is required to repress Rspondin-2 from the anterior part of the head where eventually the eyes are going to form.

"The prospect of using stem cell-based therapies to treat different types of retinal diseases is becoming a real possibility; therefore, having a better understanding of the cellular and molecular processes controlling eye morphogenesis and neuroretina differentiation is critical," Oliver said.

Further, the study showed using can accurately recreate live organs in lab-grown models, according to Oliver, opening up possibilities for future research.

"Our results further validate the organoid culture system as a reliable and fast alternative to identify and evaluate genes involved in eye morphogenesis and neuroretina differentiation in vivo," Oliver said.

Uncovering the genetics of glaucoma symptoms

Oliver also collaborated on a paper published in the Journal of Clinical Investigation, where the authors correlated alterations in one gene with glaucoma, uncovering a potential treatment pathway.

The paper identified elevated retinal pressure and impairment of cell function in mouse models when the gene angiopoietin (Angpt) and its receptor, Tie2, were turned off. The investigators traced the symptoms to a weakened pressure-relieving vessel called Schlemm's canal. Surprisingly, when they reactivated Tie2, it rejuvenated the vessel, suggesting a possible therapeutic pathway for glaucoma treatment, according to the study.

Glaucoma is a leading cause of blindness in the United States, involving the death of retinal cells caused by chronic . In healthy people, fluid builds up around the eye and drains through the Schlemm's canal or through intracellular spaces, but the majority of patients experience insufficient drainage—causing elevated pressure.

Explore further: Researchers report new paths to glaucoma treatment

More information: Jaeryung Kim et al. Impaired angiopoietin/Tie2 signaling compromises Schlemm's canal integrity and induces glaucoma, Journal of Clinical Investigation (2017). DOI: 10.1172/JCI94668

Nozomu Takata et al. An Eye Organoid Approach Identifies Six3 Suppression of R-spondin 2 as a Critical Step in Mouse Neuroretina Differentiation, Cell Reports (2017). DOI: 10.1016/j.celrep.2017.10.041

Related Stories

Researchers report new paths to glaucoma treatment

September 19, 2017
Researchers at the Center for Vascular Research, within the Institute for Basic Science (IBS), have identified a new mechanism involved in the development and progression of glaucoma, and found a potential therapeutic option ...

Research advance may lead to new treatments for glaucoma

March 22, 2016
Researchers have developed a tool to not only model the underlying disease mechanisms of glaucoma, but also to help discover and test new pharmacological strategies to combat the neurodegeneration that occurs in patients ...

Researchers use CRISPR engineering to prevent certain glaucoma in mice

October 2, 2017
A University of Iowa-led team of researchers has used the gene editing method called CRISPR-Cas9 to disrupt a mutant gene that is responsible for some forms of glaucoma, one of the most common causes of irreversible blindness.

New glaucoma cause discovered

September 9, 2014
Northwestern Medicine scientists have discovered a novel cause of glaucoma in an animal model, and related to their findings, are now developing an eye drop aimed at curing the disease. They believe their findings will be ...

Disease that causes blindness in children tied to new gene

June 10, 2016
Northwestern Medicine and University of Wisconsin-Madison (UW) scientists have identified a gene that causes severe glaucoma in children. The finding, published in The Journal of Clinical Investigation, validates a similar ...

Recommended for you

Research reveals biological mechanism of a leading cause of childhood blindness

November 16, 2017
Scientists at the Virginia Tech Carilion Research Institute (VTCRI) have revealed the pathology of cells and structures stricken by optic nerve hypoplasia, a leading cause of childhood blindness in developed nations.

Genetic treatment for blindness may soon be reality

November 11, 2017
Patients who had lost their sight to an inherited retinal disease could see well enough to navigate a maze after being treated with a new gene therapy, according to research presented today at AAO 2017, the 121st Annual Meeting ...

Study finds donor corneas can be safely preserved for longer period

November 10, 2017
Results from a large, national clinical trial show that corneal donor tissue can be safely stored for 11 days without negatively impacting the success of transplantation surgery to restore vision in people with diseases of ...

Exploring the genetics of glaucoma and retinal development

November 10, 2017
Guillermo Oliver, PhD, the Thomas D. Spies Professor of Lymphatic Metabolism, recently published two studies related to the eye, one on retinal formation and the other on the genetics behind glaucoma.

Scientists discover potential treatment to stop glaucoma in its tracks

November 6, 2017
Vision scientists at the University of California, Berkeley, and the University of Toronto have discovered that naturally occurring molecules known as lipid mediators have the potential to halt the progression of glaucoma, ...

New focus on correcting refractive vision

October 25, 2017
While doctors take delight in solving the common issue of refractive vision error by prescribing eye glasses, Flinders University researchers have found that many patients are upset with this solution and claim it affects ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.